Xilio Therapeutics, Inc. (XLO) Investor Relations Documents

Xilio Therapeutics, Inc. (XLO) investor relations documents from the company's IR site: 1 presentation, 25 press releases; latest deck 2026-08-12. Read in-app with summaries. First-party data.

Corporate Investor Presentation: Xilio's immuno-oncology platform uses masking technology to enable tumor-selective therapies with reduced side effects. Cash runway extends to Q1 2028.

Investor relations documents — source: company IR site

Published	Type	Document
2026-08-12	Presentation	Corporate Investor Presentation
2026-08-12	Press release	Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates
2026-07-06	Press release	Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-06-29	Press release	Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer
2026-05-12	Press release	Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
2026-05-07	Press release	Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-04-17	Press release	Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting C
2026-04-16	Press release	Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
2026-04-03	Press release	Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-03-23	Press release	Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
2026-03-17	Press release	Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the Ameri
2026-03-12	Press release	Read More
2026-03-02	Press release	Read More
2026-01-08	Press release	Read More
	Press release	Read More
	Press release	Read More
	Press release	Read More
	Press release	Read More
	Press release	Read More
	Press release	Read More
	Press release	Read More
	Press release	Read More
	Press release	Read More
	Press release	Read More
	Press release	Read More
	Press release	Read More

XLO overview · XLO earnings · XLO financials · XLO KPIs · XLO ownership · XLO peers · XLO filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.